EGFR and metastatic malignant neoplasm in the lymph nodes: However, EGFR+/CD3+ expression was most frequently observed in younger males (p=0.01) and associated with less lymph node metastasis (p=0.046) compared to EGFR+/CD3- patients (Table 3).